Archived Insight | June 30, 2020

COVID-19's Effect on Mortality and Pension Plans

Mortality rates vary significantly across the U.S. This will be amplified in 2020 as the impact of COVID-19 is felt differently across our communities. Why is this happening? How can we measure it? How will it affect your pension or retiree health plan?

Our panel discussion webinar offered insights about the emerging impact of COVID-19. Segal and longevity experts Club Vita described new approaches to understanding the longevity outlook of participants in your plan.

The panel also discussed how to join an industry-wide COVID-19 research project that will enable you to learn the implications for your plans.

Still have questions related to this webinar?

We have answers! Get in touch with one of our professionals and let's have a conversation today.

Learn more from our insights

Human First. AI Forward. How to Ignite Innovation and Impact with AI

AI is reshaping business—are you ready? Get clarity & actionable steps in our upcoming webinar.

Technology, Benefits Administration, Communications, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Consulting Innovation, Corporate, Benefits Technology, ATC, Organizational Effectiveness, Health, Retirement

A Diverse Group Of Professionals Is Engaged In A Lively Discussion At The Office

Multiemployer Pension Plan News for Q4 2025

See Q4 2025’s multiemployer pension plan trends: plan maturity, inflation, compliance updates and strategies for effective participant communications.

Retirement, Communications, Multiemployer Plans

Read Full Insight

Doctor Consulting With Patient During A Medical Appointment In Clinic

Q4 2025 Trends Focus: High-Cost Claims

Health plan sponsors can use data-driven strategies, preventive screenings and stop-loss coverage to lower costs and protect plan sustainability.

Health, Multiemployer Plans, Healthcare Industry, Public Sector, Higher Education, Architecture Engineering & Construction, Pharmaceutical, Corporate

Read Full Insight

Explore all COVID-19 information

We're regularly publishing information related to the coronavirus as the situation develops.

Learn More

This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.